A phase 1 study of a new therapeutic modality for the local treatment of bladder cancer: Intravesical gemcitabine plus concomitant external radiotherapy

16129 Background: Gemcitabine (G) has emerged recently as a safe and potentially active treatment for superficial bladder cancer. Gemcitabine is also considered a very potent radiosensitizing agent...